Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery vs Bromocriptine in Non-invasive Prolactinoma
NCT03353025Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2016
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of bromocriptine in prolactinoma (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Endocrine remission rate at 5 years. Started Jan 2016; status: recruiting.
02
Drugs
bromocriptine
03
Conditions
prolactinoma
Beyond the preview
Go deeper on NCT03353025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03353025.